Elaine Scott

MCSP, MPhil

Population Health, School of Medicine and Population Health

Study Manager

elaine.scott@sheffield.ac.uk
+44 114 222 5158

+44 114 273 0870 (Fax)

Room 2.11, The Innovation Centre

Full contact details

Elaine Scott
Population Health, School of Medicine and Population Health
Room 2.11
The Innovation Centre
217 Portobello
Sheffield
S1 4DP

Profile: I am currently employed as trial manager for the DAFNEplus randomised controlled trial. The trial is part of a programme funded by the NIHR, Programme Grants for Applied Research (RP-PG-0514-20013). I joined The University of Sheffield in 2012 as a trial manager in Public Health, then evaluation study manager in the Rehabilitation and Assistive Technology group of the Health Services Research Section. Before joining ScHARR I was employed as a research physiotherapist and project coordinator by Muscular Dystrophy UK working in close collaboration with a national clinical network of NHS paediatric neuromuscular centres on projects to standardise clinical assessments and to develop clinical databases. Clinical and academic leadership was from the Dubowitz Neuromuscular Centre. As part of this post I was seconded as UK Implementation Officer to the TREAT-NMD Project - an EU Funded Network of Excellence. Prior to that I was employed as a physiotherapist in the NHS, specialising in the management of adults and children with long-term neurological disability. I was awarded my MPhil, which investigated the effects of functional electrical stimulation in ambulant individuals with spinal cord injury, by Sheffield Hallam University.

Research interests

Recent projects:

NHS England New Care Models evaluations – Evaluation Programme Manager for the independent evaluation of the ‘Working Together Partnership’ Acute Care Collaboration Vanguard, and the Harrogate and Rural District Integrated Primary and Acute Care Vanguard
NHS England Perfect Patient Pathway (PePPa) Test Bed evaluation – one of the team providing an independent evaluation of the PePPa programme
Nourishing Start for Health (NoSH), Study manager for this Medical Research Council (NPRI) funded cluster RCT
HydroDMD Study: Co-applicant and member of the project management group for this NIHR HTA feasibility study

Publications

Show: Featured publications All publications

Featured publications

Journal articles

Relton C, Strong M, Thomas KJ, Whelan B, Walters SJ, Burrows J, Scott E, Viksveen P, Johnson M, Baston H , Fox-Rushby J et al (2018) Effect of Financial Incentives on Breastfeeding: A Cluster Randomized Clinical Trial.. JAMA Pediatrics, 172(2). View this article in WRRO
Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E , Epps H et al (2017) Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation. HEALTH TECHNOLOGY ASSESSMENT, 21(27). View this article in WRRO
Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E , Epps H et al (2017) Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial. Pilot and Feasibility Studies, 3, 16-16. View this article in WRRO
Relton C, Strong M, Renfrew M, Thomas K, Burrows J, Whelan B, Whitford H, Scott E, Fox-Rushby J, Anokye N , Sanghera S et al (2016) Cluster randomised controlled trial of a financial incentive for mothers to improve breast feeding in areas with low breastfeeding rates: the NOSH study protocol. BMJ Open, 6. View this article in WRRO
Mayhew AG, Cano SJ, Scott E, Eagle M, Bushby K, Manzur A & Muntoni F (2013) Detecting Meaningful Change Using The North Star Ambulatory Assessment In Duchenne Muscular Dystrophy. Developmental Medicine and Child Neurology, 55(11), 1046-1052.
Ricotti V, Ridout DA, Scott E, Quinlivan R, Robb SA, Manzur AY & Muntoni F (2012) Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy.. J Neurol Neurosurg Psychiatry.
Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, Manzur A & Muntoni F (2012) Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy. Physiotherapy Research International, 17(2), 101-109.
Mayhew A, Cano S, Scott E, Eagle M, Bushby K, Muntoni F & On Behalf of the NorthStar Clinical Network for Paediatric Neuromuscular Disease (2011) Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Developmental Medicine and Child Neurology, 53(6), 535-542.
Scott E & Mawson SJ (2006) Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. DEV MED CHILD NEUROL, 48(6), 540-544.

All publications

Journal articles

Lawton J, Rankin D, Scott E, Lorencatto F, Gericke C, Heller SR & de Zoysa N (2024) From educator to facilitator: Healthcare professionals' experiences of, and views about, delivering a type 1 diabetes structured education programme (DAFNEplus ) informed by behavioural science. Diabetic Medicine. View this article in WRRO
Coates E, Amiel S, Baird W, Benaissa M, Brennan A, Campbell M, Chadwick P, Chater T, Choudhary P, Cooke D , Cooper C et al (2021) Protocol for a cluster randomised controlled trial of the DAFNEplus (Dose Adjustment for Normal Eating) intervention compared with 5x1 DAFNE : a lifelong approach to promote effective self-management in adults with type 1 diabetes. BMJ Open, 11(1). View this article in WRRO
Relton C, Strong M, Thomas KJ, Whelan B, Walters SJ, Burrows J, Scott E, Viksveen P, Johnson M, Baston H , Fox-Rushby J et al (2018) Effect of Financial Incentives on Breastfeeding: A Cluster Randomized Clinical Trial.. JAMA Pediatrics, 172(2). View this article in WRRO
Johnson M, Whelan B, Relton C, Thomas K, Strong M, Scott E & Renfrew MJ (2018) Valuing breastfeeding: a qualitative study of women’s experiences of a financial incentive scheme for breastfeeding. BMC Pregnancy and Childbirth, 18(1). View this article in WRRO
Relton C, Thomas K, Whelan B, Scott E, Johnson M & Burrows J (2017) Evaluating the effects of financial incentives to support first-time young mothers to breastfeed. Journal of Health Visiting, 5(12), 606-610.
Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E , Epps H et al (2017) Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation. HEALTH TECHNOLOGY ASSESSMENT, 21(27). View this article in WRRO
Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, Sheehan J, Maguire C, Cantrill H, Scott E , Epps H et al (2017) Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial. Pilot and Feasibility Studies, 3, 16-16. View this article in WRRO
Relton C, Strong M, Renfrew M, Thomas K, Burrows J, Whelan B, Whitford H, Scott E, Fox-Rushby J, Anokye N , Sanghera S et al (2016) Cluster randomised controlled trial of a financial incentive for mothers to improve breast feeding in areas with low breastfeeding rates: the NOSH study protocol. BMJ Open, 6. View this article in WRRO
Whitford H, Whelan B, Van Cleemput P, Thomas K, Renfrew M, Strong M, Scott E & Relton C (2015) Encouraging breastfeeding: Financial incentives. Practising Midwife, 18(2), 18-21.
Whelan B, Thomas KJ, Cleemput P, Whitford H, Strong M, Renfrew MJ, Scott E & Relton C (2014) Healthcare providers’ views on the acceptability of financial incentives for breastfeeding: a qualitative study. BMC Pregnancy and Childbirth, 14(1), 355-355. View this article in WRRO
Mayhew AG, Cano SJ, Scott E, Eagle M, Bushby K, Manzur A & Muntoni F (2013) Detecting Meaningful Change Using The North Star Ambulatory Assessment In Duchenne Muscular Dystrophy. Developmental Medicine and Child Neurology, 55(11), 1046-1052.
Ricotti V, Ridout DA, Scott E, Quinlivan R, Robb SA, Manzur AY & Muntoni F (2012) Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy.. J Neurol Neurosurg Psychiatry.
Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, Manzur A & Muntoni F (2012) Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy. Physiotherapy Research International, 17(2), 101-109.
Mayhew A, Cano S, Scott E, Eagle M, Bushby K, Muntoni F & On Behalf of the NorthStar Clinical Network for Paediatric Neuromuscular Disease (2011) Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Developmental Medicine and Child Neurology, 53(6), 535-542.
Steffensen BF, Mayhew A, Aloysius A, Eagle M, Mercuri E, Messina S, Mazzone E, Nadeau A, Main M, Scott E , Werlauff U et al (2008) T.P.1.07 Egen classification revisited in SMA. Neuromuscular Disorders, 18(9-10), 740-741.
Scott E & Mawson SJ (2006) Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. DEV MED CHILD NEUROL, 48(6), 540-544.
Scott E & Mawson SJ () Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. Developmental Medicine & Child Neurology, 48(6), 540-544.

Conference proceedings papers

Whelan B, Strong M, Thomas K, Scott E, Easton S, Whitford H & Renfrew M (2015) ‘Paying mums to breastfeed' - can it work?. European Journal of Public Health, Vol. 25(suppl_3) View this article in WRRO
Relton C, Whelan B, Strong M, Thomas K, Whitford H, Scott E & van Cleemput P (2014) Are financial incentives for breastfeeding feasible in the UK? A mixed methods field study. The Lancet, Vol. 384 (pp S5-S5)
Mayhew AG, Eagle M, Scott E, Bushby KMD, Adnan M, Muntoni F & Cano SJ (2012) S.P.5 Trial readiness: Clinical interpretability of change scores of the North Star Ambulatory Assessment in Duchenne muscular dystropy. Neuromuscular Disorders, Vol. 22(9-10) (pp 876-877)
Ricotti V, Manzur AY, Scott E & Muntoni F (2011) P4.5 Benefits and adverse effects of glucocorticoids in boys with Duchenne Muscular Dystrophy. Neuromuscular Disorders, Vol. 21(9-10) (pp 705-706)
Guglieri M, Smith J, Eagle M, Scott E, Griggs R & Bushby K (2011) P1.34 Body mass index (BMI) and growth in Duchenne Muscular Dystrophy (DMD). Neuromuscular Disorders, Vol. 21(9-10) (pp 651-652)
Ricotti V, Manzur AY, Scott E & Muntoni F (2011) P81 Benefits and adverse effects of glucocorticoids in boys with Duchenne muscular dystrophy: a UK perspective. Neuromuscular Disorders, Vol. 21 (pp S30-S30)
Manzur AY, Scott E, Munot P, Vijaykumar K, Muntoni F & on behalf of UK NorthStar Clinica (2010) P11 UK NorthStar Neuromuscular Clinical Network (NSCN): National audit results in Duchenne muscular dystrophy (DMD) corticosteroid practice, vitamin D status and bone health. Neuromuscular Disorders, Vol. 20 (pp S8-S8)
Eagle M, Scott E, Main M, Sheehan J, Michelle M, Guglieri M, Straub V & Bushby K (2007) G.P.1.08 Steroids in Duchenne muscular dystrophy (DMD): Natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA). Neuromuscular Disorders, Vol. 17(9-10) (pp 774-774)
Acosta-Marquez C, Bradley D, Hawley M, Brownsell S, Enderby P, Buri H, Mawson S, Scott E & O'Neill P (2006) Design requirements and user interfacing for a rehabilitation robot for the lower limbs. 2006 IEEE Conference on Robotics, Automation and Mechatronics, Vols 1 and 2 (pp 499-504)